Olink® Target 96 Cardiovascular Panels
Thoroughly validated, high-performance protein biomarker panels for cardiovascular and cardiometabolic studies.
Panels
Olink Target 96 Cardiovascular II ( 92 )
This panel contains known human cardiovascular and inflammatory markers as well as some exploratory human proteins with great potential as new CVD markers.
The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.
Olink Target 96 Cardiovascular III ( 92 )
This panel contains known human cardiovascular and inflammatory markers as well as some exploratory human proteins with great potential as new CVD markers.
The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.
The cardiovascular III panel uses a 1:100 dilution of sample, whereas our technical validation assays are performed in vitro using recombinant analytes. Technical validation data reported on the biomarker pages below, and in the data validation document for this panel are based on these in vitro assays. A multiplication factor of 100 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data. Sample dilution guidelines can be found in the User Manual.
Olink Target 96 Cardiometabolic ( 92 )
The assays in this panel include proteins involved in key biological processes such as cellular metabolic process, cell adhesion, immune response and complement activation.
The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.
The cardiometabolic panel uses a 1:2025 dilution of sample, whereas our technical validation assays are performed in vitro using recombinant analytes. Technical validation data reported on the biomarker pages below, and in the data validation document for this panel are based on these in vitro assays. A multiplication factor of 2025 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data. Sample dilution guidelines can be found in the User Manual.
Related documents
Browse the entire Olink library of high quality, thoroughly validated protein biomarker assays. Search by Uniprot ID, protein name, alternative protein name or gene name.
To view more detailed information on Olink panels, you can download full validation data information for all Olink panels in the document download center.
Access all the latest technical user documentation to learn more about the functionalities of Olink products and solutions, including manuals, short instructions and guidelines.
Our analysis service offers high-capacity analysis of your samples using our Olink Explore or Olink Target platforms for protein biomarker analysis.
See what other visitors asked, to learn more about Olink technology, services and science. Search our library of information or contact our Customer Support for assistance.
2947
Biomarker assays
~881 million
Protein data points generated
1281
Publications listed on website